Interacting Drugs |
Influenza virus vaccine (live attenuated) vs Antiviral Agents (Influenza A and B) |
Security Level |
 |
Mechanism |
Antiviral Agents (Influenza A and B): May diminish the therapeutic effect of Influenza Virus Vaccine (Live/Attenuated). |
Management |
Avoid anti-influenza antivirals during the period beginning 48 hours prior to and ending 2 weeks after vaccine administration. Persons receiving these agents within 2 weeks of the live intranasal spray vaccine should receive a repeat vaccine dose. |
Influenza virus vaccine (live attenuated) vs Antiviral Agents (Influenza A and B)
Post Review about Influenza virus vaccine (live attenuated) vs Antiviral Agents (Influenza A and B) Click here to cancel reply.
Other Interactions of Influenza virus vaccine (live attenuated)
Other Interactions of Antiviral Agents (Influenza A and B)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.